Application and prospects of fecal microbiota transplantation in cancer therapy
Frontiers in Cellular and Infection Microbiology · 31.07.2026 · 16
DOI: 10.3389/fcimb.2026.1880573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 31.07.2026. Verfasst von Yu-Mei Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The 925th Hospital of PLA Joint Logistics Support Force, Guiyang, China. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Neoplasms. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the largest community of commensal microorganisms in the human body, the gut microbiota-through its structural and functional imbalances-participates in the entire process of tumor initiation and progression, and profoundly influences the efficacy and safety of conventional anticancer regimens, including chemotherapy and immunotherapy. Fecal microbiota transplantation (FMT) offers a novel biological strategy for cancer treatment by reestablishing the ecological balance of the host gut microbiota. This review systematically integrates the basic theory, clinical practice, technical optimization, epidemiological features, current challenges, and future directions of FMT in oncology. It elaborates on how FMT modulates the tumor microenvironment via core mechanisms such as immune regulation, metabolic reprogramming, and intestinal barrier repair, and shows potential value in enhancing immunotherapy responses, improving chemotherapy tolerance, and alleviating treatment-related complications across various malignancies, including colorectal cancer, liver cancer, and melanoma. Meanwhile, the article outlines practical difficulties regarding donor screening, formulation standardization, ethical oversight, and long-term safety evaluation of FMT, and looks ahead to the development of precision FMT, synthetic microbial consortia, integration of multi-omics technologies, and combination treatment paradigms. The aim is to provide a comprehensive, systematic, and academically in-depth reference for the translational and basic research of FMT in precision cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The 925th Hospital of PLA Joint Logistics Support Force, Guiyang, China.
- Department of Gastroenterology, The 923rd Hospital of PLA Joint Logistics Support Force, Nanning, China.
- Department of Cardiovascular, The Second People's Hospital of Kunming, Kunming, China.
Zitieren
APA
Fan, Y. M., Li, Y., Bi, H. Y., Ding, Y., Lyu, L., Geng, Y., & Fu, W. (2026). Application and prospects of fecal microbiota transplantation in cancer therapy. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1880573
Vancouver
Fan YM, Li Y, Bi HY, Ding Y, Lyu L, Geng Y, et al. Application and prospects of fecal microbiota transplantation in cancer therapy. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1880573
BibTeX
@article{Fan2026,
author = {Fan, Yu-Mei and Li, Yu and Bi, Hai-Yan and Ding, Yao and Lyu, Linya and Geng, Yan and Fu, Wei},
title = {Application and prospects of fecal microbiota transplantation in cancer therapy},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1880573}
}
EUVIMED